FDA Approves New Drugs and Issues Safety Warnings in April 2023 Roundup.
TL;DR Summary
The FDA approved the MiniMed 780G System for the management of type 1 diabetes mellitus, reopened the comment period for labeling of plant-based milk alternatives, authorized the Bateman Bottle Breast Implant Removal System, released educational materials on GMOs, and provided updates on COVID-19 testing. There are now 445 tests and sample collection devices authorized by the FDA under emergency use authorizations.
FDA Roundup: April 21, 2023 FDA.gov
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
93%
858 → 61 words
Want the full story? Read the original article
Read on FDA.gov